Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RX7 | Q99572 | 17/20 | 0.84 |
| ▸ | KDM1A | O60341 | 1/20 | 0.73 |
| ▸ | COL1A1 | P02452 | 2/20 | 0.70 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14513614 | 0.92 | P2RX7 (0.98) | P2RX7KDM1ACOL1A1 | |
| SCHEMBL13070373 | 0.90 | P2RX7 (0.74) | P2RX7KDM1ACOL1A1 | |
| SCHEMBL14513606 | 0.89 | P2RX7 (0.88) | P2RX7KDM1ACOL1A1 | |
| SCHEMBL298305 | 0.88 | P2RX7 (1.00) | P2RX7KDM1ACOL1A1 | |
| SCHEMBL14513610 | 0.87 | P2RX7 (0.85) | P2RX7KDM1ACOL1A1 | |
| Dehydrocorydaline SCHEMBL29396913 | 0.85 | KDM1A (1.00) | P2RX7KDM1ACOL1A1 | |
| Dehydrocorydaline SCHEMBL14513602 | 0.85 | KDM1A (1.00) | P2RX7KDM1ACOL1A1 | |
| Dehydrocorydaline SCHEMBL28839366 | 0.84 | KDM1A (0.98) | P2RX7KDM1ACOL1A1 | |
| Dehydrocorydaline SCHEMBL29695423 | 0.84 | KDM1A (0.98) | P2RX7KDM1ACOL1A1 | |
| SCHEMBL14513612 | 0.82 | P2RX7 (0.89) | P2RX7KDM1ACOL1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070098649-A1 | Method and composition for controlling oral pathogens | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (IL) | 2007-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070098649-A1 | Method and composition for controlling oral pathogens | BROX, NOP2, FBL | P2RX7 2447/4885KDM1A 3745/4885COL1A1 3755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.